SEC Form 4 · accession 0001225208-15-004177

· CYT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President, Specialty Chemicals

Period of report

Feb 12, 2015

Accepted (ET)

Feb 17, 2015 · 12:34 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000912513

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 12, 2015	M	6,410	$0.00	A	8,389	D
Common Stock^F2	Feb 12, 2015	S	2,190	$52.3607	D	6,199	D
Common Stock^F3	holding	—	—		—	7,180	I	Savings Plan

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Appreciation Right^F4	$26.24	Feb 12, 2015	D	7,500	D	—	Jan 28, 2018	Common Stock	7,500	0	D
Stock Appreciation Right^F5	$29.11	Feb 12, 2015	D	6,000	D	—	Jan 30, 2017	Common Stock	6,000	0	D

F1Pursuant to the exercise of stock settled appreciation rights, Mr. Radossich received 6,410 shares without payment of any consideration.
F2The sales price ranged from $52.35 to $52.38 with a weighted average of $52.3607. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Excludes shares held in Employees' Savings Plan or Supplemental Plan which are eligible for deferred reporting on Form 5, as per note to instruction 4(a)(i).
F4Stock settled stock appreciation rights become exercisable in one-third installments on each of the first three anniversaries of the date of grant, which was 01/29/2008.
F5Stock settled stock appreciation rights become exercisable in one-third installments on each of the first three anniversaries of the date of grant, which was 01/31/2007.